Literature DB >> 23406171

Bone mineral density is a prognostic factor for postmenopausal caucasian women with breast cancer.

Andrea Zambetti1, Paul Ian Tartter.   

Abstract

Numerous studies have convincingly shown that women with low bone mineral density have lower risk of breast cancer. As many risk factors for breast cancer are also prognostic factors, we hypothesized that women with breast cancer and low bone mineral density will have lower breast cancer recurrence rates than women with normal bone densities. A prospectively collected data base of breast cancer patients was used to identify postmenopausal Caucasian women. Their records were reviewed and 309 patients with complete follow-up and bone density tests within 1 year of their surgery were identified. The outcome of patients with low bone density (t > -1.0) was compared to the outcome for patients with normal bone density (t < -1.1). Among the 193 patients with invasive breast cancers and low bone density, distant disease-free survival at 5 years was 96% compared to 84% for 114 patients with invasive breast cancers and normal bone density (p = 0.0239). Local disease-free survival was 94% for low bone density patients compared to 86% for patients with normal bone densities (p = 0.0794). Bone mineral density is a significant prognostic factor for postmenopausal Caucasian women with breast cancer. Low bone mineral density is associated with a lower local and distant rate of recurrence.
© 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2013        PMID: 23406171     DOI: 10.1111/tbj.12072

Source DB:  PubMed          Journal:  Breast J        ISSN: 1075-122X            Impact factor:   2.431


  3 in total

1.  HIF signaling in osteoblast-lineage cells promotes systemic breast cancer growth and metastasis in mice.

Authors:  Claire-Sophie Devignes; Yetki Aslan; Audrey Brenot; Audrey Devillers; Koen Schepers; Stéphanie Fabre; Jonathan Chou; Amy-Jo Casbon; Zena Werb; Sylvain Provot
Journal:  Proc Natl Acad Sci U S A       Date:  2018-01-16       Impact factor: 11.205

2.  Evaluation of baseline fracture risk in younger postmenopausal women with breast cancer using different risk assessment methods.

Authors:  Dagmar Schaffler-Schaden; Christoph Kneidinger; Gregor Schweighofer-Zwink; Maria Flamm; Bernhard Iglseder; Christian Pirich
Journal:  Skeletal Radiol       Date:  2020-01-24       Impact factor: 2.199

3.  Postmenopausal Fracture History and Survival After Reproductive Cancer Diagnosis.

Authors:  Polly A Newcomb; Scott V Adams; Sophie Mayer; Michael N Passarelli; Lesley Tinker; Dorothy Lane; Rowan T Chlebowski; Carolyn J Crandall
Journal:  JNCI Cancer Spectr       Date:  2018-03-21
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.